Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
RESEARCH TOOLSreports
Holding RXRX?
Track your performance easily
Recursion Pharmaceuticals (RXRX) Ownership Overview
3.93% Insiders
10.86% Mutual Funds
0.08% Other Institutional Investors
20.49% ETFs
64.64% Public Companies and Individual Investors
The ownership structure of Recursion Pharmaceuticals (RXRX) stock is a mix of institutional, retail, and individual investors. Approximately 31.43% of the company’s stock is owned by Institutional Investors, 3.93% is owned by Insiders, and 64.64% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 08, 2024 | Christopher Gibson Ceo,director | xxxxxxxxxxxxx | $396200 |
| Feb 09, 2024 | Christopher Gibson Ceo,director | xxxxxxxxxxxxx | $91300 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $1226280 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $4423992 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $15255850 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $215948935 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 32,769,186 | Institution | 8.54% | 210,378,174 | |
| 30,683,747 | Institution | 8.00% | 196,989,656 | |
| 24,037,151 | Institution | 6.26% | 154,318,509 | |
| 21,173,198 | Institution | 5.52% | 135,931,931 | |
| 15,384,615 | Institution | 4.01% | 98,769,228 | |
| 12,405,955 | Institution | 3.23% | 79,646,231 | |
| 7,227,982 | Institution | 1.88% | 46,403,644 | |
| 7,067,847 | Insider | 1.84% | 45,375,578 | |
| 4,319,274 | Institution | 1.13% | 27,729,739 | |
| 3,190,194 | Insider | 0.83% | 20,481,045 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 21,173,198 | Institution | 5.52% | 135,931,931 | |
| 4,319,274 | Institution | 1.13% | 27,729,739 | |
| 2,606,698 | Institution | 0.68% | 16,735,001 | |
| 2,502,826 | Institution | 0.65% | 16,068,143 | |
| 2,436,052 | Institution | 0.63% | 15,639,454 | |
| 2,165,056 | Institution | 0.56% | 13,899,660 | |
| 1,047,231 | Institution | 0.27% | 6,723,223 | |
| 781,041 | Institution | 0.20% | 5,014,283 | |
| 745,788 | Institution | 0.19% | 4,787,959 | |
| 672,265 | Institution | 0.18% | 4,315,941 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,999,089 | Institution | 4.95% | 121,974,151 | |
| 11,642,557 | Institution | 3.03% | 74,745,216 | |
| 7,669,843 | Institution | 2.00% | 54,225,790 | |
| 6,659,384 | Institution | 1.74% | 42,753,245 | |
| 6,641,167 | Institution | 1.73% | 41,972,175 | |
| 6,254,535 | Institution | 1.63% | 44,219,562 | |
| 4,242,591 | Institution | 1.11% | 29,995,118 | |
| 3,449,128 | Institution | 0.90% | 24,385,335 | |
| 2,280,608 | Institution | 0.59% | 14,641,503 | |
| 1,933,309 | Institution | 0.50% | 12,411,844 |
FAQ
Who Owns Recursion Pharmaceuticals (RXRX)?
According to the latest TipRanks data, approximately 0.08% of the company's stock is held by institutional investors, 3.93% is held by insiders, and 64.64% is held by retail investors.
What percentage of Recursion Pharmaceuticals (RXRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.08% of Recursion Pharmaceuticals (RXRX) stock is held by institutional investors.
What percentage of Recursion Pharmaceuticals (RXRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 64.64% of Recursion Pharmaceuticals (RXRX) stock is held by retail investors.
Who owns the most shares of Recursion Pharmaceuticals (RXRX)?
Cathie Wood owns the most shares of Recursion Pharmaceuticals (RXRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.